Ahs Hospital Corp.

Ahs Hospital Corp. was paid $155.87M by Medicaid between Jan 2018 and Dec 2024, across 626 billing codes. Its largest line is 99283, emergency room visit (moderate) — 6.4% of everything it billed.

33Billing provider infoAHS HOSPITAL CORP.
MORRISTOWN, NJ 07960

33aNPI1053384776assigned 02/13/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$155.87M

24GClaims2,444,013

24DCodes billed626

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#10 of 93

Median peer was paid$30.60M

This provider vs. median5.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WALTER, JOSEPH controls 12+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	245,349	$19.15M
2019	260,663	$18.97M
2020	234,904	$15.75M
2021	355,920	$23.24M
2022	462,789	$27.50M
2023	488,829	$27.38M
2024incomplete	395,559	$23.89M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.4%	37,912	35,171	$10.05M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.1%	30,939	27,748	$9.54M
G0378	Hospital observation service, per hour	5.2%	16,619	8,044	$8.13M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	4.7%	14,221	13,095	$7.28M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.5%	18,693	16,740	$7.00M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	3.7%	5,121	4,798	$5.82M
OP710		2.6%	37,406	30,475	$4.09M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.2%	108,498	28,394	$3.50M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2.0%	677	607	$3.13M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.6%	25,462	22,052	$2.53M
J9271	Injection, pembrolizumab, 1 mg	1.6%	424	288	$2.44M
64483		1.5%	1,982	1,735	$2.31M

614 more codes

97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	1.4%	63,455	$2.19M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.4%	9,995	$2.14M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	8,140	$2.08M
96375	Therapeutic injection; each additional sequential IV push	1.3%	18,796	$2.07M
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.2%	2,744	$1.90M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	1,893	$1.73M
OP370		1.1%	11,565	$1.70M
93017		1.1%	6,936	$1.66M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.0%	9,163	$1.60M
94060		1.0%	6,148	$1.59M
OP270		<1%	49,256	$1.54M
OP272		<1%	36,414	$1.44M
95800		<1%	3,897	$1.43M
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	9,716	$1.42M
96361	Intravenous infusion, hydration; each additional hour	<1%	17,145	$1.38M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	37,488	$1.30M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,824	$1.29M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	13,161	$1.25M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,120	$1.22M
J2505	Injection, pegfilgrastim, 6 mg	<1%	270	$1.21M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,800	$1.20M
41899	Unlisted procedure, dentoalveolar structures	<1%	608	$1.19M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12,843	$1.18M
99213	Doctor's office visit, returning patient (routine)	<1%	18,936	$1.06M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,936	$1.04M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,257	$1.03M
OP250		<1%	209,968	$990K
OP278		<1%	2,206	$956K
70450	Computed tomography, head or brain; without contrast material	<1%	8,371	$890K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,307	$848K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,648	$842K
93458		<1%	313	$840K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,583	$820K
93970		<1%	3,776	$785K
93325		<1%	3,482	$785K
97161		<1%	11,858	$761K
71046	Radiologic examination, chest; 2 views	<1%	21,458	$743K
80053	Comprehensive metabolic panel	<1%	72,279	$739K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,588	$721K
78815	Positron emission tomography (PET) for limited area imaging	<1%	506	$688K
C1776	Joint device (implantable)	<1%	467	$682K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	764	$655K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	12,532	$632K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,426	$629K
76819	Fetal biophysical profile; without non-stress testing	<1%	6,062	$618K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,689	$614K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,805	$608K
J0897	Injection, denosumab, 1 mg	<1%	523	$602K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	17,786	$602K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,678	$581K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,927	$546K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	19,723	$536K
73221		<1%	858	$524K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	70,472	$510K
76830	Ultrasound, transvaginal	<1%	3,996	$508K
93320		<1%	2,047	$504K
99214	Doctor's office visit, returning patient (more involved)	<1%	10,928	$495K
96376		<1%	7,198	$488K
96417		<1%	2,271	$480K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,497	$478K
76770		<1%	3,910	$478K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,458	$464K
76641		<1%	4,068	$463K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,058	$462K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	253	$451K
90834	Psychotherapy session, about 45 minutes	<1%	15,024	$442K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	7,475	$434K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,379	$394K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	12,192	$391K
19083		<1%	310	$374K
96415		<1%	1,816	$345K
93880		<1%	1,851	$332K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,739	$318K
00731		<1%	2,309	$306K
0002A		<1%	9,173	$303K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,503	$296K
75561		<1%	526	$294K
94010		<1%	2,249	$292K
0001A		<1%	8,890	$276K
71250		<1%	1,647	$273K
72197		<1%	341	$268K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	3,742	$267K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	3,583	$266K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,462	$256K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,077	$247K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,199	$242K
93226		<1%	1,414	$241K
72141		<1%	509	$234K
75574		<1%	595	$232K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	421	$229K
64484		<1%	1,836	$228K
92587		<1%	2,402	$223K
74183		<1%	290	$221K
92557		<1%	1,847	$221K
93225		<1%	1,470	$218K
73562		<1%	4,294	$218K
76536		<1%	2,051	$216K
96367		<1%	3,930	$214K
92579		<1%	1,607	$211K
99215	Doctor's office visit, returning patient (complex)	<1%	2,542	$208K
76813		<1%	1,648	$198K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,585	$195K
00813		<1%	1,097	$194K
76642		<1%	2,251	$192K
00840		<1%	781	$190K
90791	Psychiatric diagnostic evaluation	<1%	5,203	$186K
36415	Collection of venous blood by venipuncture	<1%	106,222	$184K
71045	Radiologic examination, chest; single view	<1%	6,232	$179K
59426		<1%	3,184	$176K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,750	$171K
97165		<1%	2,997	$170K
93971		<1%	540	$166K
77066	Tomosynthesis, mammo	<1%	1,178	$166K
80048	Basic metabolic panel (calcium, ionized)	<1%	23,747	$164K
77065	Tomosynthesis, mammo	<1%	1,713	$163K
84443	Thyroid stimulating hormone (TSH)	<1%	18,075	$163K
59425		<1%	3,100	$162K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,259	$161K
86850		<1%	15,216	$160K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,849	$159K
76801		<1%	1,681	$158K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	2,219	$156K
92526		<1%	2,810	$155K
92567		<1%	3,380	$155K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	2,319	$152K
73630		<1%	3,397	$150K
73610		<1%	3,464	$149K
88341		<1%	1,232	$148K
73030		<1%	3,698	$148K
00811		<1%	822	$145K
73130		<1%	3,273	$142K
76821		<1%	1,627	$141K
00920		<1%	657	$141K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,173	$141K
77080		<1%	1,545	$138K
86900		<1%	16,819	$138K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	716	$131K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,039	$128K
C9399	Unclassified drugs or biologicals	<1%	1,689	$128K
86901		<1%	16,888	$123K
97162		<1%	1,774	$120K
99241		<1%	1,857	$117K
C1769	Guide wire	<1%	4,288	$116K
94726		<1%	1,026	$116K
73110		<1%	2,685	$113K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	3,253	$113K
97802		<1%	1,476	$111K
73560		<1%	2,666	$111K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,908	$110K
29405		<1%	262	$109K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,578	$108K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,350	$106K
64721		<1%	70	$106K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,316	$106K
76820		<1%	1,730	$104K
A9585	Injection, gadobutrol, 0.1 ml	<1%	2,577	$102K
73502		<1%	2,188	$102K
J1756	Injection, iron sucrose, 1 mg	<1%	1,749	$101K
93976		<1%	457	$100K
99153	Mod sedat endo service >5yrs	<1%	1,200	$92K
94729		<1%	1,932	$92K
84484		<1%	13,002	$92K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,208	$91K
64447		<1%	376	$90K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	5,646	$89K
74018		<1%	2,050	$88K
00812		<1%	581	$87K
88342		<1%	2,562	$82K
73590		<1%	1,829	$81K
OP258		<1%	47,176	$80K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	9,645	$78K
70486		<1%	556	$77K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,996	$76K
72100		<1%	1,783	$76K
J2704	Injection, propofol, 10 mg	<1%	22,031	$76K
96401		<1%	1,058	$75K
88307		<1%	1,249	$73K
99152		<1%	1,642	$73K
85055		<1%	1,627	$73K
88304		<1%	2,486	$69K
85027		<1%	15,878	$68K
76825		<1%	384	$68K
83735		<1%	16,902	$68K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,066	$67K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	3,749	$67K
82962		<1%	17,776	$66K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	52	$66K
77072		<1%	1,076	$65K
97803		<1%	1,420	$64K
80061	Lipid panel	<1%	11,465	$64K
36902		<1%	109	$64K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,991	$63K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,382	$62K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,960	$62K
62321		<1%	63	$61K
01400		<1%	232	$61K
77336		<1%	532	$61K
83880		<1%	5,137	$61K
73140		<1%	1,463	$61K
73564		<1%	1,472	$60K
85610		<1%	17,815	$59K
96409		<1%	246	$59K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	3,221	$58K
93296		<1%	3,357	$58K
96523		<1%	920	$56K
85730		<1%	15,264	$54K
95812		<1%	154	$54K
81001		<1%	21,436	$54K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,653	$53K
70491		<1%	224	$53K
81025		<1%	16,966	$52K
OP251		<1%	5,221	$52K
76827		<1%	382	$52K
72110		<1%	693	$51K
83605		<1%	5,995	$51K
90472	Immunization administration, each additional vaccine (list separately)	<1%	3,168	$51K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,770	$51K
92610		<1%	510	$50K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	74	$49K
87086	Culture, bacterial; quantitative colony count, urine	<1%	11,858	$49K
92523		<1%	578	$49K
73080		<1%	1,150	$46K
95782		<1%	38	$46K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	80	$46K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,619	$45K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,530	$45K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,481	$45K
70498		<1%	201	$45K
97116		<1%	2,488	$45K
72131		<1%	443	$44K
A4648	Tissue marker, implantable, any type, each	<1%	754	$43K
72170		<1%	909	$43K
87507		<1%	236	$42K
84466		<1%	6,414	$41K
36430		<1%	410	$41K
76870		<1%	440	$41K
82728		<1%	6,485	$40K
70496		<1%	149	$40K
73120		<1%	735	$39K
90715		<1%	2,709	$39K
47562		<1%	34	$39K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	3,538	$39K
83690		<1%	12,081	$39K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,342	$39K
77049		<1%	60	$39K
84702		<1%	4,027	$38K
90792	Psychiatric diagnostic evaluation with medical services	<1%	749	$38K
87040		<1%	4,715	$38K
54161		<1%	46	$38K
80076		<1%	6,611	$37K
73521		<1%	577	$37K
96411		<1%	142	$36K
99203	Doctor's office visit, new patient (routine)	<1%	803	$36K
71271		<1%	217	$35K
84145		<1%	3,096	$34K
84100		<1%	11,934	$34K
00400		<1%	170	$34K
82607		<1%	5,291	$34K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	765	$32K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	748	$31K
73100		<1%	550	$31K
82803		<1%	2,436	$31K
73090		<1%	676	$30K
59430		<1%	875	$30K
87631		<1%	464	$30K
97750		<1%	1,657	$30K
81003		<1%	15,090	$30K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,711	$30K
90832	Psychotherapy session, about 30 minutes	<1%	1,158	$29K
92611		<1%	124	$28K
87581		<1%	1,215	$27K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	739	$27K
87186		<1%	4,159	$26K
84439		<1%	4,401	$26K
87486		<1%	1,214	$26K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	3,385	$26K
88142		<1%	1,176	$25K
76818		<1%	233	$24K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	241	$24K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	16,609	$24K
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	410	$24K
87077		<1%	4,558	$24K
93280		<1%	949	$24K
0004A		<1%	695	$24K
74021		<1%	639	$23K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	744	$23K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	327	$23K
C1781	Mesh (implantable)	<1%	89	$23K
93923		<1%	137	$23K
86803		<1%	1,980	$22K
77334		<1%	47	$22K
64415		<1%	95	$21K
82746		<1%	4,117	$21K
76775		<1%	172	$21K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,238	$20K
51600		<1%	12	$20K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	21,994	$20K
93321		<1%	161	$20K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,109	$20K
99242		<1%	368	$20K
86140		<1%	7,761	$19K
86923		<1%	1,033	$19K
27447		<1%	68	$18K
73552		<1%	390	$18K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	925	$18K
88143		<1%	671	$18K
29881		<1%	13	$17K
C1874	Stent, coated/covered, with delivery system	<1%	56	$17K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,060	$17K
81002		<1%	6,550	$17K
74230		<1%	233	$16K
87070		<1%	2,613	$16K
72081		<1%	232	$16K
96137		<1%	541	$16K
72082		<1%	158	$15K
J3490	Unclassified drugs	<1%	31,451	$15K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,888	$15K
97535	Self-care/home management training, each 15 minutes	<1%	817	$15K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	15	$15K
82248		<1%	2,293	$15K
29125		<1%	389	$15K
82378		<1%	1,976	$15K
J7030	Infusion, normal saline solution , 1000 cc	<1%	12,270	$14K
OP255		<1%	5,942	$14K
96130		<1%	509	$14K
00910		<1%	85	$14K
73070		<1%	248	$14K
96136		<1%	510	$14K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,548	$14K
83540		<1%	6,416	$14K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,792	$14K
72040		<1%	319	$13K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,617	$13K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,872	$13K
12001		<1%	222	$13K
85378		<1%	3,545	$13K
51701		<1%	443	$12K
87641		<1%	1,201	$12K
72070		<1%	262	$12K
58558		<1%	13	$11K
96402		<1%	199	$11K
12011		<1%	207	$11K
95700		<1%	12	$11K
86618		<1%	796	$11K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,291	$11K
72050		<1%	134	$11K
76882		<1%	155	$11K
83037		<1%	2,257	$11K
C7900	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	3,023	$11K
85652		<1%	6,443	$10K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	68	$10K
83615		<1%	2,703	$10K
80320		<1%	212	$10K
96416		<1%	40	$10K
90674		<1%	421	$9K
82784		<1%	1,187	$9K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	27	$9K
82550		<1%	2,909	$9K
0071A		<1%	228	$9K
87205		<1%	2,008	$9K
85014		<1%	2,298	$8K
84153		<1%	1,110	$8K
74174		<1%	29	$8K
93926		<1%	53	$8K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	2,764	$8K
82330		<1%	1,218	$8K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	210	$8K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	175	$8K
0072A		<1%	205	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,645	$7K
99201		<1%	109	$7K
87075		<1%	1,091	$7K
92550		<1%	298	$7K
C1760	Closure device, vascular (implantable/insertable)	<1%	132	$7K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	228	$7K
80074		<1%	415	$7K
96450		<1%	13	$7K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	166	$7K
93298		<1%	200	$7K
82077		<1%	1,392	$6K
81401		<1%	55	$6K
01810		<1%	37	$6K
J1456	Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg	<1%	334	$6K
0011A		<1%	187	$6K
90670		<1%	1,423	$6K
0012A		<1%	184	$6K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	9,710	$6K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	51	$6K
OP229		<1%	112	$6K
J3370	Injection, vancomycin hcl, 500 mg	<1%	736	$6K
94664		<1%	262	$6K
85046		<1%	1,493	$6K
84132		<1%	1,976	$6K
77001		<1%	92	$5K
36591		<1%	644	$5K
87640		<1%	990	$5K
73565		<1%	89	$5K
87653		<1%	147	$5K
84295		<1%	1,876	$5K
86334		<1%	933	$5K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	267	$5K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,567	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,075	$5K
86038		<1%	908	$5K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	89	$5K
93308		<1%	17	$5K
90686		<1%	2,850	$5K
93299		<1%	115	$5K
0064A		<1%	148	$5K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,845	$5K
87340		<1%	661	$5K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	28	$4K
80143		<1%	933	$4K
93304		<1%	27	$4K
86304		<1%	535	$4K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	25,846	$4K
80179		<1%	917	$4K
0124A		<1%	182	$4K
64999		<1%	57	$4K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	566	$4K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,429	$4K
J2060	Injection, lorazepam, 2 mg	<1%	1,786	$4K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	4,359	$4K
90682		<1%	71	$4K
85018		<1%	2,111	$4K
73060		<1%	99	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	288	$3K
86769		<1%	122	$3K
90474		<1%	444	$3K
84481		<1%	821	$3K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	683	$3K
86480		<1%	224	$3K
73000		<1%	61	$3K
J1815	Injection, insulin, per 5 units	<1%	2,914	$3K
0054A		<1%	109	$3K
73700		<1%	14	$3K
0031A		<1%	102	$3K
51702		<1%	149	$3K
87076		<1%	226	$3K
0003A		<1%	90	$3K
82043		<1%	1,996	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	325	$3K
91320		<1%	31	$3K
96368		<1%	62	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	525	$3K
82977		<1%	1,079	$3K
88112		<1%	215	$3K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	1,929	$3K
83970		<1%	193	$3K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	91	$3K
86592		<1%	1,359	$3K
90677		<1%	212	$2K
84550		<1%	1,591	$2K
OP720		<1%	14	$2K
84425		<1%	162	$2K
J9190	Injection, fluorouracil, 500 mg	<1%	93	$2K
84134		<1%	458	$2K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	179	$2K
84165		<1%	1,096	$2K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	14	$2K
86300		<1%	283	$2K
72083		<1%	16	$2K
J9045	Injection, carboplatin, 50 mg	<1%	132	$2K
OP279		<1%	612	$2K
76885		<1%	13	$2K
96101		<1%	26	$2K
86701		<1%	161	$2K
83020		<1%	383	$2K
86481		<1%	25	$2K
77061		<1%	55	$2K
83521		<1%	472	$2K
81243		<1%	27	$2K
97164		<1%	34	$2K
90651		<1%	27	$2K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	46	$2K
86706		<1%	270	$1K
84436		<1%	278	$1K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	751	$1K
74420		<1%	12	$1K
G0379	Direct admission of patient for hospital observation care	<1%	15	$1K
84520		<1%	123	$1K
G0009	Administration of pneumococcal vaccine	<1%	154	$1K
88185		<1%	16	$1K
86665		<1%	54	$1K
G0008	Administration of influenza virus vaccine	<1%	154	$1K
74455		<1%	12	$1K
82947		<1%	51	$1K
C7901	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	147	$1K
86308		<1%	342	$1K
87536		<1%	16	$1K
C1729	Catheter, drainage	<1%	99	$999.85
84156		<1%	763	$981.47
90647		<1%	1,012	$981.37
80164		<1%	237	$971.91
81244		<1%	27	$969.57
84207		<1%	90	$965.51
88173		<1%	43	$949.23
90734		<1%	39	$900.23
95886		<1%	12	$887.61
76937		<1%	30	$860.29
82570		<1%	753	$858.45
72202		<1%	13	$850.32
83883		<1%	44	$845.29
90723		<1%	1,108	$834.71
97014		<1%	38	$820.06
90480		<1%	31	$811.07
J1650	Injection, enoxaparin sodium, 10 mg	<1%	270	$795.79
C9113	Injection, pantoprazole sodium, per vial	<1%	425	$793.03
J0780	Injection, prochlorperazine, up to 10 mg	<1%	146	$785.08
86762		<1%	164	$779.27
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,213	$773.44
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	331	$724.95
90632		<1%	101	$724.03
C1758	Catheter, ureteral	<1%	63	$723.77
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	121	$704.35
0134A		<1%	30	$702.10
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	231	$669.42
86360		<1%	17	$626.23
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	16	$622.30
J9267	Injection, paclitaxel, 1 mg	<1%	23	$606.30
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	330	$577.16
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	342	$577.16
82105		<1%	54	$571.59
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	924	$536.55
82010		<1%	101	$535.11
86328		<1%	18	$532.24
J3475	Injection, magnesium sulfate, per 500 mg	<1%	328	$523.80
90661		<1%	38	$519.14
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	357	$514.36
86664		<1%	54	$499.11
86355		<1%	17	$491.11
86357		<1%	17	$491.11
89051		<1%	240	$482.04
86359		<1%	17	$477.25
83520		<1%	58	$455.79
85347		<1%	192	$442.38
87430		<1%	58	$423.10
90688		<1%	77	$414.48
J1630	Injection, haloperidol, up to 5 mg	<1%	322	$394.47
90681		<1%	434	$391.59
96377		<1%	17	$374.07
86663		<1%	54	$366.68
86301		<1%	74	$358.62
87081		<1%	62	$347.50
88331		<1%	31	$336.89
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	93	$334.23
77062		<1%	12	$320.22
86780		<1%	42	$320.16
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	72	$283.48
93297		<1%	79	$262.14
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	65	$258.80
90633		<1%	245	$255.48
82232		<1%	42	$252.90
82247		<1%	53	$235.78
87015		<1%	90	$233.09
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	67	$227.86
82553		<1%	52	$221.80
82525		<1%	29	$217.50
84446		<1%	54	$209.32
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	13	$193.07
88184		<1%	16	$192.24
82150		<1%	71	$190.03
83516		<1%	45	$181.07
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	112	$169.42
J0461	Injection, atropine sulfate, 0.01 mg	<1%	19	$159.86
86430		<1%	106	$154.28
87799		<1%	23	$150.79
84480		<1%	35	$149.59
86880		<1%	68	$149.50
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	14	$146.87
82552		<1%	30	$140.68
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	30	$134.21
36592		<1%	70	$132.79
90710		<1%	13	$130.40
OP259		<1%	291	$125.97
86225		<1%	15	$125.04
88302		<1%	12	$120.12
87497		<1%	22	$114.81
J1171	Injection, hydromorphone, 0.1 mg	<1%	93	$114.14
80047		<1%	34	$108.49
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	17	$105.28
82040		<1%	79	$100.25
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	76	$90.82
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	693	$82.29
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	14	$66.55
82533		<1%	14	$64.79
84597		<1%	20	$61.20
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	50	$58.86
J0736	Injection, clindamycin phosphate, 300 mg	<1%	31	$57.22
89060		<1%	14	$52.32
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	53	$52.12
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	28	$47.63
J1836	Injection, metronidazole, 10 mg	<1%	46	$45.82
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	32	$43.00
82950		<1%	13	$42.90
82610		<1%	14	$39.98
82435		<1%	38	$38.20
86200		<1%	16	$25.99
80197		<1%	22	$24.16
J7510	Prednisolone oral, per 5 mg	<1%	32	$22.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	217	$21.50
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	14	$21.20
84590		<1%	20	$20.40
J2470	Injection, pantoprazole sodium, 40 mg	<1%	43	$19.30
90716		<1%	36	$17.00
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	19	$16.12
J2305	Injection, nitroglycerin, 5 mg	<1%	92	$13.13
90707		<1%	24	$13.00
J0687	Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg	<1%	80	$0.61
90656		<1%	237	$0.54
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	13	$0.00
A0021	Ambulance service, outside state per mile, transport (medicaid only)	0%	18	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	26	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	25	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWALTER, JOSEPH (SVP, CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under WALTER, JOSEPH

Full network →

Provider	Location	Paid
Ahs Hospital Corp.	Summit, NJ	$125.20M
Ahs Hospital Corp.	Pompton Plains, NJ	$36.23M
Ahs Hospital Corp	Newton, NJ	$33.62M
Ahs Hospital Corp	Hackettstown, NJ	$16.26M
Ahs Hospital Corp.	Morristown, NJ	$5.20M
Ahs Hospital Corp.	Newton, NJ	$4.82M
Ahs Hospital Corp.	Newton, NJ	$1.26M
Ahs Hospital Corp	Morristown, NJ	$171K
Ahs Hospital Corp.	Morristown, NJ	$1K
Ahs Hospital Corp.	Morristown, NJ	$1K
Ahs Hospital Corp.	Morristown, NJ	$708.57
Ahs Hospital Corp	Morristown, NJ	$149.55

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.